January 14, 2026

Vyriad raises additional $25M to fuel its genetic technology ‘race’

Vyriad, a Rochester biotech firm, recently raised an additional $25 million investment by Stine Seed Farms Inc., led by billionaire Harry Stine, to finance its clinical trial of a cancer drug.